Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Magdalena Plebanski

Showing results (211-220 of 219) with videos related to

Pageof 22
Sort By:
You have reached the last page of results.This site can display upto 219 results.
Infection and Immunity|February 21, 2002
Induction of T helper type 1 and 2 responses to 19-kilodalton merozoite surface protein 1 in vaccinated healthy volunteers and adults naturally exposed to malariaEdwin A M Lee, Dupeh R Palmer, Katie L Flanagan, et al.
Clinical & Translational Immunology|December 7, 2020
A population of CD4<sup>hi</sup>CD38<sup>hi</sup> T cells correlates with disease severity in patients with acute malariaSimon H Apte, Gabriela Minigo, Penny L Groves, et al.
BMC Health Services Research|March 21, 2026
Between silence and solutions: a global guideline review of long COVID care and services in AustraliaShiqi Luo, Zhen Zheng, Leila Karimi, et al.
Microbial Genomics|April 20, 2023
Extensive genome analysis identifies novel plasmid families in <i>Clostridium perfringens</i>Emily L Gulliver, Vicki Adams, Vanessa Rossetto Marcelino, et al.
ACS Nano|June 27, 2022
Anti-PEG Antibodies Boosted in Humans by SARS-CoV-2 Lipid Nanoparticle mRNA VaccineYi Ju, Wen Shi Lee, Emily H Pilkington, et al.
BMJ Open|May 19, 2026
Impact of long COVID on diverse Australian populations: a multi-site, longitudinal prospective cohort study protocolShiqi Luo, Zhen Zheng, Leila Karimi, et al.
Immunity|October 9, 2016
Enterococcus hirae and Barnesiella intestinihominis Facilitate Cyclophosphamide-Induced Therapeutic Immunomodulatory EffectsRomain Daillère, Marie Vétizou, Nadine Waldschmitt, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 5, 2021
Robust and prototypical immune responses toward influenza vaccines in the high-risk group of Indigenous AustraliansLuca Hensen, Thi H O Nguyen, Louise C Rowntree, et al.
Nature Communications|November 5, 2025
Olaparib, durvalumab, and cyclophosphamide, and a prognostic blood signature in platinum-sensitive ovarian cancer: the randomized phase 2 SOLACE2 trialChee Khoon Lee, Apriliana E R Kartikasari, Nirashaa T Bound, et al.
Pageof 22

Showing results (211-220 of 219) with videos related to

Sort By:
Pageof 22
You have reached the last page of results.This site can display upto 219 results.
Infection and Immunity|February 21, 2002
Induction of T helper type 1 and 2 responses to 19-kilodalton merozoite surface protein 1 in vaccinated healthy volunteers and adults naturally exposed to malariaEdwin A M Lee, Dupeh R Palmer, Katie L Flanagan, et al.
Clinical & Translational Immunology|December 7, 2020
A population of CD4<sup>hi</sup>CD38<sup>hi</sup> T cells correlates with disease severity in patients with acute malariaSimon H Apte, Gabriela Minigo, Penny L Groves, et al.
BMC Health Services Research|March 21, 2026
Between silence and solutions: a global guideline review of long COVID care and services in AustraliaShiqi Luo, Zhen Zheng, Leila Karimi, et al.
Microbial Genomics|April 20, 2023
Extensive genome analysis identifies novel plasmid families in <i>Clostridium perfringens</i>Emily L Gulliver, Vicki Adams, Vanessa Rossetto Marcelino, et al.
ACS Nano|June 27, 2022
Anti-PEG Antibodies Boosted in Humans by SARS-CoV-2 Lipid Nanoparticle mRNA VaccineYi Ju, Wen Shi Lee, Emily H Pilkington, et al.
BMJ Open|May 19, 2026
Impact of long COVID on diverse Australian populations: a multi-site, longitudinal prospective cohort study protocolShiqi Luo, Zhen Zheng, Leila Karimi, et al.
Immunity|October 9, 2016
Enterococcus hirae and Barnesiella intestinihominis Facilitate Cyclophosphamide-Induced Therapeutic Immunomodulatory EffectsRomain Daillère, Marie Vétizou, Nadine Waldschmitt, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 5, 2021
Robust and prototypical immune responses toward influenza vaccines in the high-risk group of Indigenous AustraliansLuca Hensen, Thi H O Nguyen, Louise C Rowntree, et al.
Nature Communications|November 5, 2025
Olaparib, durvalumab, and cyclophosphamide, and a prognostic blood signature in platinum-sensitive ovarian cancer: the randomized phase 2 SOLACE2 trialChee Khoon Lee, Apriliana E R Kartikasari, Nirashaa T Bound, et al.
Pageof 22